HVIVO PLC — Investor Relations & Filings
hVIVO plc is a full-service contract research organization (CRO) and a leading specialist in human challenge trials. The company provides end-to-end clinical development solutions for a global biopharma client base, focusing on infectious and respiratory diseases. Its services span from preclinical consultancy to Phase III clinical trials, including first-in-human studies, biometry, and consulting. hVIVO operates a state-of-the-art quarantine facility in London and provides advanced laboratory services under its hLAB brand. Through subsidiaries such as CRS and Venn Life Sciences, it offers early-phase clinical trial expertise and patient recruitment across multiple clinical sites. The company's integrated approach is designed to accelerate the development of vaccines and therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Consultancy contract with Decoy Therapeutics | 2026-06-01 | English | |
| Grant of awards under Long Term Incentive Plan | 2026-05-29 | English | |
| Group of companies' accounts made up to 2025-12-31 | 2026-05-29 | English | |
| Capital Markets Day | 2026-05-20 | English | |
| Result of AGM | 2026-05-13 | English | |
| Holding(s) in Company | 2026-05-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47916895 | Consultancy contract with Decoy Therapeutics | 2026-06-01 | English | ||
| 47878575 | Grant of awards under Long Term Incentive Plan | 2026-05-29 | English | ||
| 47905660 | Group of companies' accounts made up to 2025-12-31 | 2026-05-29 | English | ||
| 46579419 | Capital Markets Day | 2026-05-20 | English | ||
| 45604509 | Result of AGM | 2026-05-13 | English | ||
| 45196271 | Holding(s) in Company | 2026-05-12 | English | ||
| 42452157 | £6m Influenza HCT contract signed | 2026-05-07 | English | ||
| 36206442 | Director/PDMR Shareholding | 2026-04-24 | English | ||
| 35137173 | HCT contract signed with ILiAD Biotechnologies | 2026-04-22 | English | ||
| 34661204 | Annual Report & Notice of AGM | 2026-04-17 | English | ||
| 34655198 | hVIVO launches unified brand identity | 2026-04-14 | English | ||
| 34655136 | Influenza HCT contract signed with Traws Pharma | 2026-04-14 | English | ||
| 33684812 | Notice of Results | 2026-04-07 | English | ||
| 33051244 | Holding(s) in Company | 2026-03-26 | English | ||
| 32851117 | Holding(s) in Company | 2026-02-27 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for HVIVO PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
PACIFIC EDGE LIMITED
Develops non-invasive molecular tests for bladder cancer de…
|
PEB | NZ | Professional, scientific and te… |
|
PARADIGM BIOPHARMACEUTICALS LIMITED..
Repurposing PPS for osteoarthritis and rare inflammatory di…
|
PAR | AU | Professional, scientific and te… |
|
Pasithea Therapeutics Corp.
Develops treatments for central nervous system disorders, R…
|
KTTA | US | Professional, scientific and te… |
|
Passage BIO, Inc.
A clinical-stage genetic medicines company developing thera…
|
PASG | US | Professional, scientific and te… |
|
PATRYS LIMITED
Develops Deoxymab antibody therapies targeting DNA repair m…
|
PAB | AU | Professional, scientific and te… |
|
PAVmed Inc.
A diversified medical technology company developing devices…
|
PAVM | US | Professional, scientific and te… |
|
PegBio Co., Ltd.
Specializes in discovering and developing innovative therap…
|
2565 | HK | Professional, scientific and te… |
|
PELL BMT
Develops advanced cell and gene therapies, including CAR-T …
|
6949 | TW | Professional, scientific and te… |
|
PepGen Inc.
Develops oligonucleotide therapeutics for neuromuscular and…
|
PEPG | US | Professional, scientific and te… |
|
PERCHERON THERAPEUTICS LIMITED
Clinical-stage developer of antisense pharmaceuticals for r…
|
PER | AU | Professional, scientific and te… |
HVIVO PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7697/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7697 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7697 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7697 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7697}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HVIVO PLC (id: 7697)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.